Scion Medical Limited

Scion Medical Limited is a medical device company founded in 2011, with its headquarters located in Hangzhou, China. The company established a U.S. subsidiary, Scion Medical Technologies, LLC and a China subsidiary Alicon Pharmaceutical Sci & Tec Co., Ltd., and was acquired by Varian Medical Systems in 2019 as part of a dual transaction that also included Endocare, Inc. Business/Product Breakdown Scion Medical Limited develops and manufactures interventional oncology devices, primarily embolic microspheres for transarterial chemoembolization in the treatment of liver cancer. Its flagship products include DC Bead and DC Bead LUMI, drug-eluting and radiopaque beads designed to deliver chemotherapeutic agents directly to tumor sites while occluding blood supply to the malignancy. The company operates manufacturing facilities in China compliant with international standards and supports global distribution through regulatory clearances in the United States, Europe, and Asia. Following the acquisition, its technology has been integrated into broader oncology treatment platforms.